Robert W. Baird Lowers Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $73.00
Praxis Precision Medicines (NASDAQ:PRAX – Free Report) had its price objective trimmed by Robert W. Baird from $117.00 to $73.00 in a research report report published on Monday morning,Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts have also weighed in on PRAX. HC Wainwright restated […]
Praxis Precision Medicines (NASDAQ:PRAX – Free Report) had its price objective trimmed by Robert W. Baird from $117.00 to $73.00 in a research report report published on Monday morning,Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts have also weighed in on PRAX. HC Wainwright restated […]
